NAPORAFENIB
UNII 15JL80DG6H

Substance Identification & Data

This profile provides standardized clinical and technical data for Naporafenib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 15JL80DG6H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1800398-38-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

15JL80DG6H

CAS Registry Number

1800398-38-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NAPORAFENIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C25H25F3N4O4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UEPXBTCUIIGYCY-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C125003

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

90456533

Unique identification number in the NCBI database of chemical substances.

INN ID

11398

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-238

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

Cc1ccc(NC(c2ccnc(C(F)(F)F)c2)=O)cc1-c3cc(OCCO)nc(N4CCOCC4)c3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Naporafenib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.